Goodman reports that he consults the pathway every day. “It’s helped standardize the care I provide to ensure there’s no gaps in how I’m treating patients.”
Clinical Topics
-
COVID can mimic prostate cancer symptoms -
Improving Bone Health in Patients With Advanced Prostate Cancer With the Use of Algorithm-Based Clinical Practice Tool at Salt Lake City VA -
Palliative Care Disparities in Small Cell Carcinoma of the Prostate: An Analysis of the National Cancer Database -
Impact of Race on Outcomes of High-Risk Patients With Prostate Cancer Treated With Moderately Hypofractionated Radiotherapy in an Equal Access Setting -
Concordance of DNA Repair Gene Mutations in Paired Primary Prostate Cancer Samples and Metastatic Tissue or Cell-free DNA
Digital Edition
Multimedia
Conference Coverage
-
Transgender Women and Prostate Cancer: It’s Complicated -
A Phase II Study With Androgen Deprivation Therapy and Up-Front Radiotherapy in High-Intermediate and High-Risk Prostate Cancer With Stereotactic Body Radiation Therapy to Pelvic Nodes and Concomitant Prostate Boost by Simultaneous Integrated Boost -
Do We Need More Screen Time? Patterns of Telehealth Utilization for Patients With Prostate Cancer in the Veterans Health Administration (VHA) -
Metastatic Prostate Cancer Presenting as Pleural and Pericardial Metastases: A Case Report and Literature Review -
Creating a Urology Prostate Cancer Note, a National Oncology and Surgery Office Collaboration for Prostate Cancer Clinical Pathway Utilization -
Impact of Stewardship Assistance Pilot Program for Veterans on Adherence and Persistence to Oral mCRPC Therapies -
Experts Focus on Quality-of-Life Data in Prostate Cancer -
AVAHO Mtg: Germline Testing Key for Vets With High-Risk PC -
How Long Should Active Surveillance Last? -
Question 1 of 5
